Wed, 20 Oct 2021

According to a report by Reports and Data, the Continuous Glucose Monitoring devices market was valued at USD 3.45 Billion in 2019 and is estimated to reach USD 14.7 billion by 2026, growing at a CAGR of 19.2%. Estimating and identifying appropriate blood glucose level in patients through continuous glucose monitoring (CGM) devices is a vital component of therapy success. Continuous glucose monitoring evolved from enzyme-based electrochemical glucose sensors. It is an instrument with a small sensor attached with a transmitter for daily diabetes management. The Continuous Glucose Monitoring devices aid in better diabetes management by proactively tracking glucose level fluctuations in interstitial fluid as a basis for improving metabolic control. CGM devices help in reducing the risk of hyperglycemia & hypoglycemia.

The global spread of diabetes along with increasing geriatric population and continuous technological advancements have propelled the market growth of the CGM devices. According to the WHO, Diabetes is increasing at an alarming rate in the United States, and nearly 30.3 million people, or 9.4% of the U.S. population, have diabetes. An estimated 23.1 million people - or 7.2% of the population - had diagnosed diabetes. North America accounts for the largest share in the global continuous glucose monitoring devices market due to government initiatives undertaken for prevention of diabetes and treatment support along with the presence of dominant players in this region, technological advancements in the drug discovery procedures, growing rate of obesity in the region, sedentary lifestyle and techno savvy population.

While, there are certain restraining factors which stand as potential challenges to the market growth. Inadequate reimbursement and high cost associated with the application of CGM devices, measurement reliability, human factors issues, lack of a standardized format for displaying results, and uncertainty pertaining to the best use of CGM data to make therapeutic decisions are some of the key factors hampering the growth of this market during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2172

The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.

Key players in the market include

Dexcom, Abbott Laboratories, Pfizer Inc., Inc. Baxter International, Menarini Diagnostics, Johnson & Johnson, Medtronic PLC, Animas Corporation, and Novo Nordisk A/S, ARKRAY, Inc., Bayer AG, Terumo Medical Corporation, Echo Therapeutics, Inc.; Medtronic PLC; F. Hoffmann-La Roche Ltd., GlySens Incorporated

Furthermore, the report segments Continuous Glucose Monitoring Devices market on the basis of key product types and applications and provides details about the revenue growth, revenue CAGR, and revenue share each segment is expected to register over the forecast period.

By Component (Revenue, USD Million; 2017-2027)

  • Insulin Pumps
  • Transmitters & receivers
  • Sensors

By End-Use (Revenue, USD Million; 2017-2027)

  • Hospitals
  • Homecare settings
  • Others

For a better understanding of the global Continuous Glucose Monitoring Devices market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market. It provides insights into production and consumption patterns, supply and demand ratio, export/import, current and emerging trends and demands, market share, market size, revenue contribution, and presence of key players in each region.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2172

In-depth regional analysis includes:

  • North America (U.S., Canada, Mexico)
  • Europe (Italy, U.K., Germany, France, Rest of EU)
  • Asia Pacific (India, China, Japan, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report @ https://www.reportsanddata.com/report-detail/continuous-glucose-monitoring-devices-market

Benefits of the Global Continuous Glucose Monitoring Devices Report:

  • Comprehensive analysis of the opportunities and risks of the Continuous Glucose Monitoring Devices market
  • Detailed study of the latest product and technological developments and innovations of the Continuous Glucose Monitoring Devices market
  • Business strategies and plans are analysed for understanding the Continuous Glucose Monitoring Devices market scenario
  • Revenue forecast of Continuous Glucose Monitoring Devices market for the forecast period 2020-2027
  • Comprehensive analysis of the drivers, constraints, limitations, challenges, and opportunities
  • Latest and emerging market trends analysis and their impact on product and application demand
  • Study of recent M&A, joint ventures, collaborations, partnerships, product launches and brand promotions among others
  • Extensive SWOT analysis and Porter's Five Forces analysis along with investment return analysis and feasibility

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2172

Thank you for reading our report. Please get in touch with us to know more about the report and customization of the report. Our team will ensure the report is tailored to meet your requirements.

Browse More Reports :

Roadside Drug Testing Devices Market Size

Implantable Ports Market Trends

Urinary Incontinence Market Statistics

Medical Robots Market Report

Surgical Apparel Market Companies

Tags: , ,

See Campaign: https://www.reportsanddata.com/report-detail/continuous-glucose-monitoring-devices-marketContact Information:John W

Head of Business Development

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Reports and Data | Web: www.reportsanddata.com

News: www.reportsanddata.com/market-newsTags:PR-Wirein, Reportedtimes, Menafn, iCN Internal Distribution, Research Newswire, English

Sign up for Miami News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!